Who still needs surgical staging of the axilla for invasive breast cancer?
Kathryn KelleyStephen F SenerPublished in: Journal of surgical oncology (2024)
Sentinel lymphadenectomy may be safely omitted for postmenopausal patients with low-risk estrogen-receptor-positive cancers who have a negative pretreatment axillary ultrasound. Surgical staging should still be done for patients who are premenopausal or postmenopausal with high-risk estrogen receptor-positive cancers, for those having neoadjuvant chemotherapy, or those with estrogen-receptor-negative or human epidermal growth factor receptor-positive cancers.
Keyphrases
- estrogen receptor
- neoadjuvant chemotherapy
- lymph node
- sentinel lymph node
- epidermal growth factor receptor
- end stage renal disease
- locally advanced
- tyrosine kinase
- chronic kidney disease
- breast cancer risk
- early stage
- endothelial cells
- newly diagnosed
- bone mineral density
- advanced non small cell lung cancer
- postmenopausal women
- magnetic resonance imaging
- pet ct
- prognostic factors
- patient reported outcomes
- induced pluripotent stem cells
- computed tomography
- rectal cancer
- patient reported
- contrast enhanced ultrasound